Today in News History
On July 12, several notable moments in the history of News stand out. In 813, Byzantine emperor Michael I, under threat by conspiracies, abdicates in favor of his general Leo the Armenian, and becomes a monk (under the name Athanasius). In 1754, Thomas Bowdler, English physician and philanthropist (died 1825) was born. In 1798, The United States Marine Corps is re-established; they had been disbanded after the American Revolutionary War. In 1953, Ivan Toms, South African physician and activist (died 2008) was born. In 1955, Balaji Sadasivan, Singaporean neurosurgeon and politician, Singaporean Minister of Health (died 2010) was born. In 1962, Project Apollo: At a press conference, NASA announces lunar orbit rendezvous as the means to land astronauts on the Moon, and return them to Earth. In 1977, Martin Luther King Jr., assassinated in 1968, is awarded the Presidential Medal of Freedom. In 1978, Massimiliano Rosolino, Italian swimmer was born. In 1989, Shimanoumi Koyo, Japanese sumo wrestler was born. In 2008, Michael E. DeBakey, American surgeon and educator (born 1908) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
A patient got the weight loss medication retatrutide before FDA approval. How does that work?
A primer on retatrutide and compassionate use
Narrative Intelligence Brief
This article was published by PolitiFact, a source frequently categorized with a center bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of PolitiFact, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from PolitiFact
July 10, 2026
Donald Trump - Trump exaggerates about how much illegal immigration raised rental housing prices
July 9, 2026
What Trump’s communism claims miss about Democrats and democratic socialists
July 9, 2026
Paul Renner - FL governor’s race: Did Jay Collins sponsor a bill giving permanent tax breaks to AI data centers?
July 8, 2026
Fact-checking Abdul El-Sayed and Haley Stevens in MI Democratic Senate primary debate
July 8, 2026
Fact-checking the first debate between Ed Markey, Seth Moulton in Massachusetts U.S. Senate contest
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"cup semifinals"
Jude Bellingham's star shines as risk-averse England advance to World Cup semifinals over tepid Norway
Bellingham carries England past Norway and into World Cup semifinals
England defeat Norway 2-1 as Jude Bellingham shines in World Cup quarterfinal
How other outlets are covering this story
Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
6 sources
Left 33%
Center 17%
Right 50%
Voice of Nigeria
· Jun 29, 2026
FDA Reviews Sandoz Generic Obesity Drug Applications
The U.S. Food and Drug Administration (FDA) has accepted for review two generic versions of tirzepatide developed by Swiss pharmaceutical company Sandoz, a move that could pave the way for increased competition in the rapidly expanding obesity and diabetes treatment market. If approved, the medicines would become direct competitors to Eli Lilly’s blockbuster tirzepatide brands, [] The post FDA Reviews Sandoz Generic Obesity Drug Applications appeared first on Voice of Nigeria.
Proto Thema - English
· Jul 1, 2026
Obesity: Free medication program ends as Health Ministry seeks two-month extension
If the extension is not approved, the disruption will affect only July and August, as the entire Prevent program is expected to resume with national funding from September, the Prime Minister announced at the ygeiamou.gr health conference The post Obesity: Free medication program ends as Health Ministry seeks two-month extension appeared first on ProtoThema English.
9 News Australia
· Jul 8, 2026
The weightloss pill that could change the game for Aussies | 9 News Australia
Doctors say a pill version of the weightloss injectable Wegovy will make treatment more accessible for Australians. It's just been launched in the UK, but the green light is yet to be given by Australia's medical watchdog for two oral GLP-1 medications. #9News | Subscribe and 🔔: http://9Soci.al/KM6e50GjSK9 | Get more breaking news at nine.com.au FOLLOW 9News Australia ► Facebook: https://www.facebook.com/9News/ ► X: https://twitter.com/9NewsAUS ► Instagram: https://www.instagram.com/9news/ ► TikTok: https://www.tiktok.com/@9news Join 9News for the latest in news and events that affect you in your local city, as well as news from across Australia and the world. #BREAKINGNEWS #9NEWS #AUSTRALIA
Medical Daily
· Jul 2, 2026
A New Drug Just Became the First Approved for Both Active and Chronic Thyroid Eye Disease
FDA approved veligrotug (Lumvoa) for both active and chronic thyroid eye disease — a first. Here's who qualifies, what the evidence shows, and what changes for the 50,000–100,000 Americans affected annually.
Kaiser Health
· Jun 26, 2026
Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know
If your doctor prescribes a GLP-1 medication for weight loss but your insurance won’t cover it, you have options.
Gizmodo
· Jul 8, 2026
11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy
15 of Americans have ever taken the drugs, up from 6 in 2024.
Topics:
Related coverage for "A patient got the weight loss medication retatrutide before FDA approval. How does that work?": Voice of Nigeria — FDA Reviews Sandoz Generic Obesity Drug Applications. Proto Thema - English — Obesity: Free medication program ends as Health Ministry seeks two-month extension. 9 News Australia — The weightloss pill that could change the game for Aussies | 9 News Australia. Medical Daily — A New Drug Just Became the First Approved for Both Active and Chronic Thyroid Eye Disease. Kaiser Health — Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know. Gizmodo — 11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy